Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POMPAE trial of perioperative magnesium to prevent postoperative atrial fibrillation after cardiac surgery
NL-OMON24637Not yet recruiting
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Atrial fibrillation (AFib) comparing Magnesium sulfate with Placebo (2 arms). Primary endpoints: Incidence of postoperative atrial fibrillation within 7 days after surgery and Newly diagnosed atrial fibrillation lasting 5 minutes or longer. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON24637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24637.